In conclusion, metformin significantly inhibits the brain metastasis potential of BR cells by suppressing the expression of SPANXB1, suggesting that SPANXB1 is a key molecular target for metformin on breast cancer cells. The gene discussed is SPANXB1; the disease is breast carcinoma.